Significance of serum leucine aminopeptidase in tumours of female genital tract.
J Indian Med Assoc
;
1989 Mar; 87(3): 68-70
Artigo
em Inglês
| IMSEAR
| ID: sea-105717
ABSTRACT
Serum leucine aminopeptidase (LAP) was estimated in 57 female patients with tumours of the genital tract and compared with 50 age-matched controls. Serum LAP was increased in leiomyomas (p less than 0.01) but significant rise was seen in leiomyosarcomas and endometrial carcinoma of the uterus (p less than 0.001). No increase in serum LAP level, above mean control value was observed in carcinoma of cervix. LAP levels were also increased in cystadenomas of the ovary (p less than 0.01) and highly significant increase, noted in cystadenocarcinomas and dysgerminoma stage III (p less than 0.001). However, no increase of enzyme activity was observed in poorly differentiated papillary carcinoma of the ovary. The serum enzyme level was higher in cystadenocarcinomas as compared to solid ovarian carcinomas in the same clinical stage.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Prognóstico
/
Feminino
/
Humanos
/
Biomarcadores Tumorais
/
Adulto
/
Neoplasias dos Genitais Femininos
/
Leucil Aminopeptidase
Tipo de estudo:
Estudo prognóstico
Idioma:
Inglês
Revista:
J Indian Med Assoc
Ano de publicação:
1989
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS